Johnson & Johnson to Participate in the UBS Global Healthcare Conference

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)-- Johnson & Johnson (NYSE: JNJ) will present at the UBS Global Healthcare Conference on Tuesday, November 11th, 2025. Management will participate in a Fireside Chat at 11:00 a.m. Eastern Time.

A live audio webcast of the presentation will be accessible through Johnson & Johnson’s Investor Relations website at www.investor.jnj.com. An archived edition of the session will be available later that day.

The audio webcast replay will be available approximately 48 hours after the webcast.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251009718064/en/

Media contact:
[email protected]

Investor contact:
[email protected]

Source: Johnson & Johnson

You May Also Be Interested In

• Croma-Pharma Introduces saypha® volume prime Lidocaine
• Cencora Elects Robert E. Sanchez to Its Board of Directors
• Trustar Bankshares, Inc. Announces $28.1 Million Private Placement Financing to Support Continued Growth